Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2012
News by month December 2012
PTCommunity News December 2012
FDA Grants Accelerated Approval for Sirturo (Bedaquiline) as Part of Combination Therapy for Adults With Drug-Resistant TB
Researchers Find Molecular Mechanism Responsible for OA Pain
Cancer Screening Rates Decline in U.S.
Mixed Results in Phase III Trial of Pain Drug for Knee Surgery
FDA Approves Eliquis (Apixaban) to Reduce Stroke, Blood Clots in Patients With Atrial Fibrillation
Research Offers New Target for Stroke Treatments
Alzheimer’s Association Publishes Assessment Recommendations
Urine Test for Kawasaki Disease
Phase III Results Announced for Protease Inhibitor Simeprevir in Hepatitis C Patients
FDA Approves IV Immune Globulin, Bivigam, for Immunodeficiency
Report: Ulcerative Colitis Drug Market Will Double Over Next Decade
Link Between Diabetes, High Blood Pressure, and Colon Cancer Recurrence
New Compound Reverses Fatty Liver Disease
CDC Analysis: HIV Cases Decline for Black Women, Increase for Gay Men
Positive Phase III Results for Skin-Infection Drug Oritavancin
Positive Safety Results for IV Stem-Cell Therapy in Rheumatoid Arthritis
Lung Cancer Drug Fails Phase III Trial
New Type of Antibiotic May Defeat Drug-Resistant Bugs
Blood Test Predicts Lymphedema
Researchers Find Way to Make One-Time Flu Vaccine
Mobile App Helps Providers Better Document Conditions and Care
Report: Sales of Antiretroviral Agents for HIV Will Decline Slightly Over Next Decade
New Guidelines for Treating Severe Heart Attack
Positive Phase II Results for Psoriasis Drug Ponesimod
Health-System Analysis: Higher Postsurgical Opioid Use Linked to Extended Hospital Stay and Increased Cost of Care
FDA Approves Signifor (Pasireotide Diaspartate) for Cushing’s Disease
CMS Announces Continued Progress in Setting Up Health Insurance Marketplaces
Pediatricians Say Thimerosal Should Stay in Global Vaccine Supply
Scientists Discover Gene Linked to Breast and Ovarian Cancer
FDA Approves Four-Strain Seasonal Influenza Vaccine
FDA Accepts New Drug Application for Bazedoxifene/Conjugated Estrogens, Investigational Treatment for Menopause and Osteoporosis
Hypercholesterolemia Drug Kynamro (Mipomersen) Gets ‘Thumbs Down’ in Europe
FDA Okays Iclusig (Ponatinib) for Leukemia
Dogs Can Sniff Out ‘Superbug’ Infections
Brain Chemical Linked to Suicidal Behavior
FDA Accepts NDA Submission for New Antidepressant Drug, Vortioxetine
Investigational Kinase Inhibitor Fostamatinib Inferior to Humira in Phase II Trial
New Hormone Therapy Shows Promise for Menopausal Symptoms
Positive Phase III Results for Oncolytic Virus, Reolysin, in Head-and-Neck Cancers
Report: Medical Advances Reshape Health Landscape Worldwide — But Not Always for the Better
Phase III Studies: Ruxolitinib (Jakavi) Reduces Disease Burden in Patients With Myelofibrosis
Pancreas Size Linked to Increased Risk for Type 1 Diabetes
Next Steps for Solanezumab, Potential Alzheimer’s Drug
Industry Sponsorship Influences Clinical Trial Findings, Researchers Claim
Report: Health Insurance Costs Rose Faster Than Income in All States From 2003 to 2011
FDA Expands Use of Abiraterone (Zytiga) for Late-Stage Prostate Cancer
Report: Third-Generation Antiepileptic Drugs Expected to Fuel Growth of Epilepsy Market Through 2021
Positive Phase III Results for Revlimid Plus Low-Dose Dexamethasone in Refractory Multiple Myeloma
NIH-Funded Trial Will Assess New TB Drug
Popular Weight-Loss Drug May Be Toxic
Pertuzumab (Perjeta) Extends Survival in Patients With Metastatic Breast Cancer
Apixaban (Eliquis) Reduces Recurrence of Blood Clots in Phase III Trial
Investigational Drug Ponatinib Curbs Chronic Leukemia
Metformin Improves BMI and Blood Glucose Levels in Obese Children
Researchers Find New Way to Attack Stomach-Ulcer Bug
Report Foresees Declining Sales for Bisphosphonates in Osteoporosis Market
Severe Acute Kidney Injuries Rise Nationwide
Antidepressant Drug Targets Brain Receptors in New Way
Thalidomide Derivative Studied in Cutaneous Lupus Erythematosus
Phase III Study: No Difference Between Eribulin (Halaven) and Capecitabine (Xeloda) in Breast Cancer Survival
Children With HIV Have Increased Risk of Atherosclerosis
Galantamine (Razadyne) Lowers Mortality in Alzheimer’s Patients
Adult Antiviral Drug Suppresses Hepatitis B in Teens
New Blood Test for Children With Autism
Discovery of Molecular Pathway for Depression Reveals New Drug Targets
Cabozantinib (Cometriq) Shows Promise in Prostate Cancer Spread to Bone
Breath Test May Help Diagnose Colorectal Cancer
Report: Substantial Growth Expected in Gout Drug Market
Updated Phase III Survival Data for Faslodex (Fulvestrant) in Breast Cancer
Surgeons Implant Brain ‘Pacemaker’ for Alzheimer’s Disease
‘Nanobubbles’ Kill Diseased Cells While Leaving Healthy Cells Untouched
Rayos (Delayed-Release Prednisone) Launched in U.S.
FDA Announces Partnership to Speed Patient Access to New Medical Devices
Report: NSCLC Drug Market Expected to Grow Over Next Decade
New Study: Copper May Prevent Spread of Drug-Resistant Infections
Positive Phase III Results for Gattex (Teduglutide) in Short Bowel Syndrome
FDA Panel Has Mixed Opinion of Vibativ (Telavancin) for Nosocomial Pneumonia
Potential Drug Target May Curb Hospital-Acquired Infection
Breathalyzer for Diagnosis of Lung Diseases
FDA Accepts Pediatric NDA for Proton Pump Inhibitor AcipHex (Rabeprazole)
FDA Updates Labeling for Viagra, Cialis, and Levitra for Rare Reports of Eye Problems
